AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

RVF and Other Emerging Infectious Diseases in East and Central Africa

Recruitingn/aAges 2 Years - anyAllWashington State University
💬

In plain words

What the trial is, and whether it could suit you

Rift Valley fever (RVF), a disease transmitted from livestock (cattle, sheep, goats, camels) to humans more commonly occurs in the East and Central Africa (ECA) regions where more than 15 major epidemics affecting more than one country have been reported over the past 50 years. Within the region, there are specific areas, referred to as hotspots, which support RVF virus maintenance via low-level virus circulation between animals, humans, and mosquitoes. Most outbreaks originate from these hotspots. Our goal is to conduct studies in RVF hotspots in four ECA countries, Kenya, Uganda, Tanzania, and Democratic Republic of Congo (DRC) to determine the burden of RVF disease among humans, wildlife and livestock during inter-epidemic periods (IEPs) and discover circulation of undetected infectious diseases. This information is important for use in developing an early warning system and possibly

Sign in to get the eligibility rules as simple questions to take to your doctor.

📋 Eligibility rules (as published)
Inclusion Criteria for health facility based study: Category A: A sample of patients presenting to the health facility meeting this inclusion criteria will be enrolled: • Persons ≥ 10 years of age who are malaria negative AND have undifferentiated acute fever at the time of presentation (≥ 37.5°C) or reported fever in the past 4 weeks. Category B: A sample of patients presenting to the health facility meeting this inclusion criteria will be enrolled: • Persons ≥ 10 years of age who are malaria positive AND have undifferentiated acute fever at the time of presentation (≥ 37.5°C) or reported fever in the past 4 weeks. Category C: All patients at the health facility meeting these criteria will be enrolled in the study Persons ≥ 10 years of age with: • Unexplained bleeding with or without fever manifesting as either: Blood in vomitus, Bleeding from the gums, Bleeding from the nose, Bleeding in the eyes (red eyes), Non-menstrual genital bleeding, Bleeding from any other body site OR • Infectious disease illness of unknown etiology requiring hospitalization. The illness should not be responding to antimalarials and/or antibiotics following 7 days of treatment Inclusion Criteria for community cross sectional study: Member of household 2 or more years of age. Exclusion Criteria: Those who do not consent or refuse written consent. If a participant is severely ill and has no next of kin to provide consent +/- witness on their behalf. If a participant is known to have blood clotting disorders, allergies arising from injections, or if a participant has ever fainted during previous injections or blood collection
💊

What it tests

  • Evidence of past or recent RVF exposure
📍

Where

10 sites
Virunga Hospital & North Kivu
Goma, Democratic Republic of the Congo
South Kivu
Bukavu, Democratic Republic of the Congo
Tana River County
Hola, Kenya
Isiolo county
Isiolo, Kenya
Marsabit county
Marsabit, Kenya
Muranga county
Murang’a, Kenya
Iringa
Iringa, Tanzania
Rwekubbo health centre IV & Isingiro district
Isingiro, Uganda

…and 2 more on ClinicalTrials.gov.

🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy